ViBA

Simulation of clinical trials of oral treprostinil in pulmonary arterial hypertension using a virtual population.

Stine AE, Parmar J, Smith AK · NPJ systems biology and applications · 2025 · Article

10.1038/s41540-024-00481-y

Verified evidence

Model evaluation

d4900b1d-3e64-5980-99bb-8ff59a76092b
Treatment response and effect measures

Prediction source Version of record · PDF page(s) 3, 5

Study 1e6df6a9-baa1-58c0-b9ae-a094d506de5e · Prediction record (JSON)

Prediction fields

Concrete comparator
virtual FREEDOM-M trial treatment-placebo effect versus the published clinical FREEDOM-M treatment-placebo effect · PDF page(s) 3
Endpoint
six_minute_walk_distance__between_group_treatment_effect · PDF page(s) 3, 5
Family
clinical_outcomes · PDF page(s) 3, 5
Measured variable
six_minute_walk_distance · PDF page(s) 3, 5
Metric
between_group_treatment_effect · PDF page(s) 3, 5
Reference type
observed_clinical_reference · PDF page(s) 1, 5
Reported time window
week 12 treatment-effect assessment in the clinical and sampled FREEDOM-M virtual trials · PDF page(s) 5
Role
simulated_output · PDF page(s) 3, 5
Scenario
simulated_trial_and_published_cohort_comparison · PDF page(s) 3, 5

Pulmonary arterial hypertension virtual-trial QSP model implementation · Corresponding author · Study code request · Prediction-linked resource · PDF page 10 · Restricted availability reported by the authors · Curated resource record

Validation Direct comparison · Unknown · Unknown · Partial support · Partially comparable · Not applicable